Get Live Data

REMINDER: Our user survey closes on Friday, please submit your responses here. 

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Int.biotech. Share Price
  4. Int.biotech. Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksInt.biotech. Regulatory News (IBT)

Int.biotech. Information

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 642.00
Bid: 636.00
Ask: 642.00
Change: 2.00 (0.31%)
Spread: 6.00 (0.943%)
Open: 640.00
High: 642.00
Low: 638.00
Prev. Close: 640.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

27 Mar 2024 17:02

RNS Number : 5795I
Intl. Biotechnology Trust PLC
27 March 2024
 

Transaction in own shares

International Biotechnology Trust plc (the "Company") announces that on Wednesday 27 March 2024 it purchased 15,000 of its ordinary shares at a price of 656.5184 pence per share, to be held in treasury.

Following this purchase, the Company's issued share capital consists of 41,383,817 ordinary shares of 25p each, the total number of shares in treasury is 3,366,410 and the total number of voting rights in the Company is 38,017,407.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Enquiries:

Schroder Investment Management Limited

Tel: 020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDDLFLZXLBBBF
67891011121314
Date   Source Headline
24th Mar 20235:34 pmRNSTransaction in Own Shares
22nd Mar 20235:11 pmRNSTransaction in Own Shares
21st Mar 20238:00 amRNSPortfolio Update
17th Mar 20234:54 pmRNSTransaction in Own Shares
16th Mar 20235:10 pmRNSTransaction in Own Shares
15th Mar 20235:12 pmRNSTransaction in Own Shares
15th Mar 20234:24 pmRNSTransaction in Own Shares
13th Mar 20234:10 pmRNSTransaction in Own Shares
13th Mar 202312:32 pmRNSPortfolio Update
7th Mar 20234:59 pmRNSTransaction in Own Shares
2nd Mar 20235:29 pmRNSTransaction in Own Shares
21st Feb 20237:00 amRNSPortfolio Update
13th Feb 20237:00 amRNSInvestment Management Update
7th Feb 20239:00 amRNSDirector Declaration
2nd Feb 20237:00 amRNSPortfolio Update
23rd Jan 20235:22 pmRNSAppointment of Non-executive Director
23rd Jan 20237:00 amRNSPortfolio Update
3rd Jan 20237:00 amRNSBlock listing Interim Review
19th Dec 20229:00 amRNSPortfolio Update
14th Dec 20227:00 amRNSPortfolio Update
12th Dec 20222:23 pmRNSPortfolio Update
8th Dec 20227:47 amEQSHardman & Co Research on International Biotechnology Trust (IBT): Low FDA activity may drive further M&A
6th Dec 20224:24 pmRNSDividend Declaration
6th Dec 20224:18 pmRNSResult of AGM
1st Dec 20222:38 pmRNSTotal Voting Rights
17th Nov 20228:00 amRNSPortfolio Update
9th Nov 20224:48 pmRNSTransaction in Own Shares
8th Nov 20224:41 pmRNSTransaction in Own Shares
7th Nov 20225:20 pmRNSTransaction in Own Shares
4th Nov 20224:40 pmRNSTransaction in Own Shares
3rd Nov 20224:57 pmRNSTransaction in Own Shares
1st Nov 20225:22 pmRNSTransaction in Own Shares
1st Nov 202211:26 amRNSTotal Voting Rights
1st Nov 20227:00 amRNSAnnual Financial Report
31st Oct 20225:20 pmRNSTransaction in Own Shares
27th Oct 20225:33 pmRNSTransaction in Own Shares
26th Oct 20224:39 pmRNSTransaction in Own Shares
25th Oct 20228:00 amRNSPortfolio Update
24th Oct 20225:12 pmRNSTransaction in Own Shares
18th Oct 20225:36 pmRNSTransaction in Own Shares
17th Oct 20221:16 pmRNSTransaction in Own Shares
13th Oct 20225:55 pmRNSTransaction in Own Shares
13th Oct 20227:00 amRNSKepler Trust Intelligence: New Research
3rd Oct 202212:07 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSCompliance with the Market Abuse Regulation
20th Sep 20225:22 pmRNSTransaction in Own Shares
20th Sep 20228:00 amRNSPortfolio Update
25th Aug 20228:30 amRNSPortfolio Update
1st Aug 202211:12 amRNSTotal Voting Rights
22nd Jul 20223:29 pmRNSDividend Declaration
67891011121314

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.